Corvus Pharmaceuticals
CRVS • NASDAQ
Corvus Pharmaceuticals is a biotechnology company in the healthcare sector trading on NASDAQ, led by CEO Richard A. Miller, with a market cap of $1.3B.
Market Cap$1.3B
Employees28.0
CEORichard A. Miller
CountryUnited States of America
Healthcare
Biotechnology
Next EarningsMay 7, 2026 · In 3 weeksQ1 2026
Financials
Corvus Pharmaceuticals FAQ
Common questions about Corvus Pharmaceuticals
Corvus Pharmaceuticals is scheduled to report earnings for Q1 2026 on May 7, 2026. Analysts estimate revenue of $620.0K.
Corvus Pharmaceuticals has approximately 28 employees.